title: pH-mediated field-amplified sample stacking of pharmaceutical cations in high-ionic strength samples.
abstract: Capillary electrophoretic separation of samples of physiological origin typically have both poor resolution and efficiency due to destacking. We have previously reported a stacking method for concentration of catecholamines in artificial dialysate, or Ringer's solution. However, pH-mediated sample stacking of other cations has not been investigated. In this report, pH-mediated stacking has been extended to eletripan, dofetilide, doxazosin, sildenafil, UK-103,320, UK-202,581, and CP-122,288. These compounds were chosen without prior structural screening except that they were cationic at the pH of our background electrolyte (BGE). Capillary electrophoretic behavior of samples in BGE is compared with those of samples in Ringer's solution with and without pH-mediated acid stacking. Results indicate that the peak heights and efficiencies for acid-stacked samples are increased compared to the unstacked samples in Ringer's solution or BGE. For example, the peak efficiencies for 5 s injections of eletriptan in BGE and Ringer's solution are 138,000 and 72,000 plates, respectively. In contrast, a 10 s injection of eletriptan followed by acid injection for 16 s produces a peak with 246,000 plates. Evaluation of the stacking effect was performed by comparison of the peak height at similar peak efficiencies for samples in Ringer's solution with and without stacking. Using this method, pH-mediated acid stacking provides a 10- to 27-fold sensitivity enhancement for the seven cations.
authors.affiliation: Department of Chemistry, University of Kansas, Lawrence, KS, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Weiss
authors.forename: K
authors.initials: K
authors.lastname: Saunders
authors.forename: C E
authors.initials: CE
authors.lastname: Lunte
mesh_terms: D002412:Cations; D017292:Doxazosin / Q000302:isolation & purification; D019075:Electrophoresis, Capillary / Q000379:methods*; D006863:Hydrogen-Ion Concentration; D007211:Indoles / Q000302:isolation & purification; D007552:Isotonic Solutions; D009994:Osmolar Concentration; D010627:Phenethylamines / Q000302:isolation & purification; D010879:Piperazines / Q000302:isolation & purification; D011687:Purines; D011744:Pyrimidinones / Q000302:isolation & purification; D011759:Pyrrolidines / Q000302:isolation & purification; D000077331:Ringer's Solution; D000068677:Sildenafil Citrate; D013449:Sulfonamides / Q000302:isolation & purification; D013450:Sulfones; D018170:Sumatriptan / Q000031:analogs & derivatives* / Q000302:isolation & purification; D014363:Tryptamines
chemical_list: D002412:Cations; D007211:Indoles; D007552:Isotonic Solutions; D010627:Phenethylamines; D010879:Piperazines; D011687:Purines; D011744:Pyrimidinones; D011759:Pyrrolidines; D013449:Sulfonamides; D013450:Sulfones; D014363:Tryptamines; C109995:UK 103320; C085263:CP 122288; C115647:eletriptan; D000077331:Ringer's Solution; D018170:Sumatriptan; D000068677:Sildenafil Citrate; D017292:Doxazosin; C063533:dofetilide